Company Search:
Advanced Search
Sponsored Links
Glyconex Incorporation Company Snapshot
Glyconex Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Glyconex Incorporation with three other companies in this sector in Taiwan: Intech Biopharm Ltd (2015 sales of 9.77 million Taiwanese Dollars [US$320,259.93 ] ), Fountain Biopharma Inc (5.28 million Taiwanese Dollars [US$173,065.62 ] of which 100% was Medicine), and Lumosa Therapeutics Co Ltd (9.52 million Taiwanese Dollars [US$312,291.96 ] ).

Sales Analysis. Glyconex Incorporation reported sales of 6.96 million Taiwanese Dollars (US$228.25 thousand) for the year ending December of 2015. This represents a decrease of 11.6% versus 2014, when the company's sales were 7.87 million Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Glyconex Incorporation
  Stock Performance Chart for Glyconex Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 30.05
(Figures in Taiwanese Dollars)
1 Week -2.8%   13 Weeks -8.0%  
4 Weeks -9.4%   52 Weeks -29.0%  
Glyconex Incorporation Key Data:
  Ticker: 4168 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 6,961,000
(Year Ending Jan 2016).
Employees: 32
  Currency: Taiwanese Dollars Market Cap: 2,274,995,350
  Fiscal Yr Ends: December Shares Outstanding: 75,707,000
  Share Type: Gu Closely Held Shares: 26,792,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.